⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31115566 | 0.89 | — | — | |
| SCHEMBL30957810 | 0.89 | — | — | |
| SCHEMBL12094920 | 0.89 | — | — | |
| SCHEMBL31399069 | 0.89 | — | — | |
| SCHEMBL18869 | 0.87 | — | — | |
| Charcoal, Activated SCHEMBL34461824 | 0.82 | — | — | |
| SCHEMBL31149825 | 0.76 | — | — | |
| SCHEMBL14639124 | 0.75 | — | — | |
| SCHEMBL2162034 | 0.75 | — | — | |
| SCHEMBL2162036 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12597182-B2 | Data interpolation platform for generating predictive and interpolated pricing data | Caplight Technologies, Inc. (US) | 2026-04-07 | — | — | US | claimed |
| EP-4646220-A1 | COMBINATION THERAPY OF APELIN RECEPTOR AGONIST AND GLP-1 RECEPTOR AGONIST FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH WEIGHT GAIN | Bioage Labs, Inc. (US) | 2025-11-12 | — | — | EP | claimed |
| US-12394123-B2 | Data interpolation platform for generating predictive and interpolated pricing data | Caplight Technologies, Inc. (US) | 2025-08-19 | — | — | US | claimed |
| US-20250238981-A1 | DATA INTERPOLATION PLATFORM | Caplight Technologies, Inc. (US) | 2025-07-24 | — | — | US | claimed |
| CN-116185075-B | Collaborative terminal guidance method for intercepting high-speed and high-maneuvering targets | 西北工业大学 | 2025-06-24 | — | — | CN | claimed |
| CN-120070855-A | Knowledge-guided camouflage target detection method and system | 武汉大学 | 2025-05-30 | — | — | CN | claimed |
| CN-119882527-A | Discrete clean robot controller | 天津新松智能科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119807315-A | Computing and application service optimization method based on two-dimensional and three-dimensional space information | 河南省地球物理空间信息研究院有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119707281-A | Fluorescent glasses and glass ceramics with high cerium and tin content | 义获嘉伟瓦登特公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119650844-A | High-safety high-voltage halogenated ether-phosphate cosolvent electrolyte and lithium battery | 西南石油大学 | 2025-03-18 | — | — | CN | claimed |
| CN-106103572-A | Highly fluorinated elastomer | 3M创新有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-104817512-B | A kind of synthetic method of oxazolines pharmaceutical intermediate compound | 吉林百年汉克制药有限公司 | 2016-09-21 | — | — | CN | claimed |
| US-9353077-B2 | Organocatalytic process for asymmetric synthesis of decanolides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-05-31 | — | — | US | claimed |
| CN-104817512-A | Synthetic method of oxazoline medical intermediate compound | LIU ZENGFENG | 2015-08-05 | — | — | CN | claimed |
| US-20150210665-A1 | ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-07-30 | — | — | US | claimed |
| CN-104010505-A | Pesticidal compositions and methods related thereto | DOW AGROSCIENCES LLC | 2014-08-27 | — | — | CN | claimed |
| WO-2014037964-A2 | ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2014-03-13 | — | — | WO | claimed |
| EP-1599190-A2 | CONTROLLED RELEASE MODIFYING COMPLEX AND PHARMACEUTICAL COMPOSITIONS THEREOF | Glenmark Pharmaceuticals Limited (IN) | 2005-11-30 | — | — | EP | claimed |
| US-20040185097-A1 | Controlled release modifying complex and pharmaceutical compositions thereof | GLENMARK PHARMACEUTICALS LTD. | 2004-09-23 | — | — | US | claimed |
| WO-2004066910-A2 | CONTROLLED RELEASE MODIFYING COMPLEX AND PHARMACEUTICAL COMPOSITIONS THEREOF | GLENMARK PHARMACEUTICALS LTD. (US) | 2004-08-12 | — | — | WO | claimed |